Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.45 |
| ▸ | MITF | O75030 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | TP53 | P04637 | 4/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | STAT6 | P42226 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Damsin SCHEMBL18642932 | 0.75 | PTGS2 (0.55) | PAX8PTGS2MITFCYP3A4LMNA | |
| Damsin SCHEMBL18642934 | 0.75 | PTGS2 (0.55) | PAX8PTGS2MITFCYP3A4LMNA | |
| SCHEMBL21765578 | 0.74 | PAX8 (0.30) | PAX8 | |
| SCHEMBL29355617 | 0.73 | PAX8 (0.45) | PAX8PTGS2TDP1ALDH1A1PKM | |
| SCHEMBL18550778 | 0.69 | PAX8 (0.47) | PAX8PTGS2NLRP3PKMMAPT | |
| Ambrosin SCHEMBL3463664 | 0.68 | MAPT (0.54) | PAX8PTGS2CYP3A4LMNATP53 | |
| Ambrosin SCHEMBL3463663 | 0.68 | MAPT (0.54) | PAX8PTGS2CYP3A4LMNATP53 | |
| Coronopilin SCHEMBL8422737 | 0.67 | PAX8 (1.00) | PAX8PTGS2CYP3A4LMNATP53 | |
| SCHEMBL21563385 | 0.64 | UBE2D3 (0.49) | PTGS2CYP3A4LMNATP53CYP2D6 | |
| SCHEMBL13940415 | 0.63 | PAX8 (0.41) | PAX8PTGS2CYP3A4LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240224882-A1 | LIGHT SOURCE | SEOUL VIOSYS CO LTD (KR) | 2024-07-11 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11778953-B2 | Light source for plant cultivation | SEOUL VIOSYS CO., LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-20220192103-A1 | LIGHT SOURCE FOR PLANT CULTIVATION | SEOUL VIOSYS CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2021-06-01 | — | — | US | disclosed |
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345167-A1 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | MCL1, BCL9L, DLD | PAX8 4324/4885PTGS2 2995/4885MITF 4033/4885 |
| US-11021488-B2 | Hetero-substituted cyclic lactone analogues and uses thereof | MCL1, BCL9L, DLD | PAX8 4324/4885PTGS2 2995/4885MITF 4033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.